Combining Social Networking and Medical Innovation

Posted by: in Healthcare Insights, Social Media Insights & Trends on February 3, 2011

Drug discovery is often a serendipitous process. While some blockbusters can be meticulously designed, many more have been the result of chance: a unique compound buried in the dirt of some faraway land, an unexpected “side effect” that proves a breakthrough, a treasure from the animal kingdom.

Speeding up serendipity, then, is a huge and worthwhile goal, but one that is — almost by definition — tricky to pull off. That’s what makes a column in the Boston Globe last week by two Theravance* researchers — Dr. David Shaywitz and Dr. Mathai Mammen — so interesting. They suggest a social-networking driven web of patients and doctors could help identify heretofore unrecognized benefits of existing drugs, helping push forward both science and clinical benefit.

On its own, the idea has considerable merit. At a time when analysts are predicting we’ll have a billion smartphones in use by 2013, there are a lot of opportunities for a lot of people to painlessly share a lot of data. To be sure, there are obstacles, some scientific, some regulatory, some practical. But, as a concept, it’s a fantastic idea.

Beyond whatever scientific benefits such a network could bring, it might also serve an even more important goal: getting the public more aware of — and invested in — biomedical research. Even as the pharmaceutical and biotechnology industry spends billions in research and development, a disproportionately huge amount of news flow focuses on drug marketing and advertising. While this isn’t a very good representation of how the industry actually spends its money, it’s not surprising: it’s easy to write about because consumers get exposed to advertising on a daily basis. The work of innovation — the reality of life in the laboratory — is nearly invisible to most people.

Shaywitz and Mammen’s network might help to change that . Participants would be more aware that they are part of a high-risk, high-reward endeavor in which their input could change the face of medicine, even if most of the activities of this network don’t yield actionable results.

Last week, President Obama made the case that innovation will be key to “winning the future.” But innovation, up close, isn’t always exciting. That doesn’t make it any less important, and anything that helps make innovation more tangible has the potential to change the way people view the critical investments in R&D that both private industry and the government are making.

* WCG has worked with Theravance in the past, though we were not involved in Shaywitz and Mammen’s piece in the Globe in any way.

By: Brian Reid

Brian Reid is a managing director at W2O Group, where he oversees influencer relations. He is a former journalist who believes content really is king.

Find me on: Twitter
Pre-Commerce Check out W2O Group President Bob Pearson's new book, Pre-Commerce, in which he shares ideas for leaders to engage directly with customers to shape their brand and marketplace success. Now available for order on Amazon.com! http://amzn.to/bAmvFN. Join the conversation #precommerce.

One Response

Stay in touch with the conversation, subscribe to the RSS feed for comments on this post.

  1. I continue to be intrigued by any efforts to build on the basic premise that our social networks and relationships can be used to positively influence our health. I was not familiar with this work, but am excited to learn more about it – so thanks for sharing, Brian!
    I also wanted to call attention to an existing social network – exclusively focused on patients – that has a similar philosophical underpinning:
    CureTogether.com allows patients to anonymously track 3 basic things relative to any health condition they have: Their symptoms, their treatments, and the effectiveness of those treatments.
    It’s amazing how rich – and surprising – that data set can be, encompassing 10s of thousands of patients and hundreds of conditions. As of my last contact with the founders of the site (Alexandra Carmichael and Daniel Reda), there were a number of companies interested in using the site for research … and the patient testimonials about how the use of the site positively impacted the way that they live with their conditions are truly inspiring.
    I’d love to see more on this topic as it evolves – thanks again, Brian, for bringing it forward.

Some HTML is OK

(required)

(required, but never shared)

or, reply to this post via trackback.